Morgan Stanley Upgrades Qiagen to Overweight, Raises Price Target to $42
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsUpgradesPrice Target
Morgan Stanley analyst Steve Beuchaw upgrades Qiagen (NYSE:QGEN) from Equal-Weight to Overweight and raises the price target from $40 to $42.
Morgan Stanley analyst Steve Beuchaw upgrades Qiagen (NYSE:QGEN) from Equal-Weight to Overweight and raises the price target from $40 to $42.